These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16835013)

  • 1. Culture serum-induced conversion from agonist to antagonist of a Vitamin D analog, TEI-9647.
    Yamaoka K; Kim MS; Takada I; Takeyama K; Kamimura T; Kato S
    J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):177-83. PubMed ID: 16835013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling.
    Peräkylä M; Molnár F; Carlberg C
    Chem Biol; 2004 Aug; 11(8):1147-56. PubMed ID: 15324816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of the vitamin D antagonistic actions of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone depends on the primary structure of the carboxyl-terminal region of the vitamin d receptor.
    Ochiai E; Miura D; Eguchi H; Ohara S; Takenouchi K; Azuma Y; Kamimura T; Norman AW; Ishizuka S
    Mol Endocrinol; 2005 May; 19(5):1147-57. PubMed ID: 15650022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators.
    Issa LL; Leong GM; Sutherland RL; Eisman JA
    J Bone Miner Res; 2002 May; 17(5):879-90. PubMed ID: 12009019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
    Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
    Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of the selective activity of vitamin D analogues.
    Carlberg C
    J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of the histidine-mediated vitamin D receptor agonistic and antagonistic mechanisms of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone.
    Kakuda S; Ishizuka S; Eguchi H; Mizwicki MT; Norman AW; Takimoto-Kamimura M
    Acta Crystallogr D Biol Crystallogr; 2010 Aug; 66(Pt 8):918-26. PubMed ID: 20693691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor.
    Gonzalez MM; Samenfeld P; Peräkylä M; Carlberg C
    Mol Endocrinol; 2003 Oct; 17(10):2028-38. PubMed ID: 12843209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly potent vitamin D receptor antagonists: design, synthesis, and biological evaluation.
    Saito N; Kittaka A
    Chembiochem; 2006 Oct; 7(10):1479-90. PubMed ID: 16871612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 22S-butyl-1alpha,24R-dihydroxyvitamin D3: recovery of vitamin D receptor agonistic activity.
    Inaba Y; Nakabayashi M; Itoh T; Yoshimoto N; Ikura T; Ito N; Shimizu M; Yamamoto K
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):146-50. PubMed ID: 20211257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Methylene 19-nor-25-dehydro-1alpha-hydroxyvitamin D3 26,23-lactones: synthesis, biological activities and molecular basis of passive antagonism.
    Yoshimoto N; Inaba Y; Yamada S; Makishima M; Shimizu M; Yamamoto K
    Bioorg Med Chem; 2008 Jan; 16(1):457-73. PubMed ID: 17904370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification.
    Tocchini-Valentini G; Rochel N; Wurtz JM; Moras D
    J Med Chem; 2004 Apr; 47(8):1956-61. PubMed ID: 15055995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H; Spinner D; Reddy GS; Lindley IJ
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: active vitamin D analogues with 22R-alkyl group.
    Anami Y; Itoh T; Egawa D; Yoshimoto N; Yamamoto K
    J Med Chem; 2014 May; 57(10):4351-67. PubMed ID: 24742174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
    Hourai S; Rodrigues LC; Antony P; Reina-San-Martin B; Ciesielski F; Magnier BC; Schoonjans K; Mouriño A; Rochel N; Moras D
    Chem Biol; 2008 Apr; 15(4):383-92. PubMed ID: 18420145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
    Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
    Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog.
    Takeyama K; Masuhiro Y; Fuse H; Endoh H; Murayama A; Kitanaka S; Suzawa M; Yanagisawa J; Kato S
    Mol Cell Biol; 1999 Feb; 19(2):1049-55. PubMed ID: 9891040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.
    Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-mediated conformational changes of the VDR are required for gene transactivation.
    Carlberg C
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):227-32. PubMed ID: 15225776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.